A $106 million drug contract just buys more of the same, for years

The US government committed $106 million to buy pharmaceutical products from Catalyst Pharmaceuticals. This contract ensures a supply of existing drugs but does not change how they are made or delivered.

This contract is a large purchase of existing drugs. It does not introduce new manufacturing methods, alter drug pricing structures, or change how the government procures pharmaceuticals. It simply ensures a continued supply of what is already available.